Logo
x

Search

Subscribe Now

Genentech

Genentech Reports the FDA's sBLA Acceptance for Gazyva to Treat Lupus Nephritis

Genentech Reports the FDA's sBLA Acceptance for Gazyva to Treat Lupus Nephritis

  • March 5, 2025
Genentech Reports Data from P-III (BALATON and COMINO) Trials of Vabysmo (faricimab-svoa) for Macular Edema due to Retinal Vein Occlusion

Genentech Reports Data from P-III (BALATON and COMINO) Trials of Vabysmo (faricimab-svoa) for Macular Edema due to Retinal Vein Oc...

  • February 1, 2024
Genentech Reports the Results of Inavolisib Combination Therapy in P-III Trial for the Treatment of Breast Cancer

Genentech Reports the Results of Inavolisib Combination Therapy in P-III Trial for the Treatment of Breast Cancer

  • December 5, 2023
Genentech’s Vabysmo (faricimab-svoa) Receives the US FDA’s Approval for the Treatment of Retinal Vein Occlusion

Genentech’s Vabysmo (faricimab-svoa) Receives the US FDA’s Approval for the Treatment of Retinal Vein Occlusion

  • October 27, 2023
PharmaShots Weekly Snapshots (October 09–13, 2023) _

PharmaShots Weekly Snapshots (October 09–13, 2023) _

  • October 14, 2023
Genentech Reports P-III Study (OCARINA II) Results of Ocrevus for the Treatment of Multiple Sclerosis

Genentech Reports P-III Study (OCARINA II) Results of Ocrevus for the Treatment of Multiple Sclerosis

  • October 12, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.